Essential medicines and health products

Good Governance for Medicines (GGM) Overview

The GGM programme was launched in 2004 with the goal of contributing to health systems strengthening and preventing corruption by promoting good governance in the pharmaceutical sector.


Good governance is critical to universal health coverage

The Good Governance for Medicines programme commemorates 10 years of operation with a consultation of Member States, partners and other stakeholders in WHO’s South East Asian and Western Pacific Regions in Manila.

  • To raise awareness on the impact of corruption in the pharmaceutical sector and bring this to the national health policy agenda
  • To increase transparency and accountability in medicine regulatory and supply management systems
  • To promote individual and institutional integrity in the pharmaceutical sector
  • To institutionalize good governance in pharmaceutical systems by building national capacity and leadership.

GGM programme approach

The concept underlying the GGM approach is that by supporting policy-makers and national officials to understand where the strengths and weaknesses lie in national pharmaceutical systems, appropriate interventions can be developed and applied.

Country progress

With the support of the German Federal Ministry for Economic Cooperation and Development and the Government of Kuwait the programme has grown to include 36 participating countries.

Key tools

Background documents

  • World Health Report 2010
    Background Paper, No. 25 : WHO Good Governance for Medicines programme: an innovative approach to prevent corruption in the pharmaceutical sector